• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

费城染色体阴性骨髓增殖性疾病患者的隐匿性脑梗死

Covert Brain Infarcts in Patients with Philadelphia Chromosome-Negative Myeloproliferative Disorders.

作者信息

Kuznetsova Polina I, Raskurazhev Anton A, Konovalov Rodion N, Krotenkova Marina V, Chechetkin Andrey O, Lagoda Olga V, Melikhyan Anait L, Tanashyan Marine M

机构信息

Department of Angioneurology, Research Center of Neurology, 125367 Moscow, Russia.

Neuroimaging Department, Research Center of Neurology, 125367 Moscow, Russia.

出版信息

J Clin Med. 2021 Dec 21;11(1):13. doi: 10.3390/jcm11010013.

DOI:10.3390/jcm11010013
PMID:35011753
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8745571/
Abstract

BACKGROUNDS AND PURPOSE

Philadelphia chromosome-negative myeloproliferative disorders (Ph-negative MPD) are a rare group of hematological diseases, including three distinct pathologies: essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PMF). They most often manifest with thrombotic complications, including cerebrovascular events. Covert brain infarcts (CBIs) are defin ed as predominantly small ischemic cerebral lesions that are detected using magnetic resonance imaging (MRI) in the absence of clinical stroke events. The relationship between MPD and CBIs remains unclear.

METHODS

Included in the study were 103 patients with the diagnosis of Ph-MPD (according to WHO 2016 criteria) (median age-47 (35; 54) years; 67% female). In total, 38 patients had ET, 42 had PV, and 23 had PMF. They underwent clinical examination, routine laboratory analyses (complete blood count), brain MRI, ultrasound carotid artery, flow-mediated dilatation (as a measure of endothelial dysfunction-FMD).

RESULTS

Overall, 23 patients experienced an ischemic stroke (as per MRI and/or clinical history), of which 16 (15.5%) could be classified as CBIs. The rate of CBIs per MPD subtype was statistically non-significant between groups ( = 0.35): ET-13.2%, PV-21.4%, and PMF-8.7%. The major vascular risk factors, including arterial hypertension, carotid atherosclerosis, and prior venous thrombosis, were not associated with CBIs ( > 0.05). Age was significantly higher in patients with CBIs compared to patients without MRI ischemic lesions: 50 (43; 57) years vs. 36 (29; 48) ( = 0.002). The frequency of headaches was comparable between the two groups. CBIs were associated with endothelial dysfunction (OR - 0.71 (95% CI: 0.49-0.90; = 0.02)) and higher hemoglobin levels (OR-1.21 (95% CI: 1.06-1.55); =0.03).

CONCLUSIONS

CBIs are common in patients with Ph-negative MPD. Arterial hypertension and carotid atherosclerosis were not associated with CBIs in this group of patients. The most significant factors in the development of CBIs were endothelial dysfunction (as measured by FMD) and high hemoglobin levels. Patients with Ph-negative MPD and CBIs were older and had more prevalent endothelial dysfunction.

摘要

背景与目的

费城染色体阴性骨髓增殖性疾病(Ph阴性MPD)是一组罕见的血液系统疾病,包括三种不同的病理类型:原发性血小板增多症(ET)、真性红细胞增多症(PV)和原发性骨髓纤维化(PMF)。它们最常表现为血栓形成并发症,包括脑血管事件。隐匿性脑梗死(CBI)被定义为主要是小的缺血性脑病变,在无临床中风事件的情况下通过磁共振成像(MRI)检测到。MPD与CBI之间的关系仍不清楚。

方法

该研究纳入了103例诊断为Ph-MPD的患者(根据WHO 2016标准)(中位年龄47(35;54)岁;67%为女性)。其中,38例患有ET,42例患有PV,23例患有PMF。他们接受了临床检查、常规实验室分析(全血细胞计数)、脑部MRI、颈动脉超声、血流介导的血管舒张功能检测(作为内皮功能障碍的指标-FMD)。

结果

总体而言,23例患者发生了缺血性中风(根据MRI和/或临床病史),其中16例(15.5%)可归类为CBI。各MPD亚型的CBI发生率在组间无统计学差异(P = 0.35):ET为13.2%,PV为21.4%,PMF为8.7%。主要血管危险因素,包括动脉高血压、颈动脉粥样硬化和既往静脉血栓形成,与CBI无关(P>0.05)。与无MRI缺血性病变的患者相比,CBI患者的年龄显著更高:50(43;57)岁对36(29;48)岁(P = 0.002)。两组头痛频率相当。CBI与内皮功能障碍相关(OR - 0.71(95%CI:0.49 - 0.90;P = 0.02))和较高的血红蛋白水平相关(OR - 1.21(95%CI:1.06 - 1.55);P = 0.03)。

结论

CBI在Ph阴性MPD患者中很常见。在这组患者中,动脉高血压和颈动脉粥样硬化与CBI无关。CBI发生的最重要因素是内皮功能障碍(通过FMD测量)和高血红蛋白水平。Ph阴性MPD和CBI患者年龄更大,内皮功能障碍更普遍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0901/8745571/47611c8049db/jcm-11-00013-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0901/8745571/988b675ed84a/jcm-11-00013-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0901/8745571/d5adbf5ec12e/jcm-11-00013-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0901/8745571/47611c8049db/jcm-11-00013-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0901/8745571/988b675ed84a/jcm-11-00013-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0901/8745571/d5adbf5ec12e/jcm-11-00013-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0901/8745571/47611c8049db/jcm-11-00013-g003.jpg

相似文献

1
Covert Brain Infarcts in Patients with Philadelphia Chromosome-Negative Myeloproliferative Disorders.费城染色体阴性骨髓增殖性疾病患者的隐匿性脑梗死
J Clin Med. 2021 Dec 21;11(1):13. doi: 10.3390/jcm11010013.
2
Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.费城染色体阴性骨髓增殖性肿瘤的临床表现及并发症危险因素
Asian Pac J Cancer Prev. 2015;16(12):5013-8. doi: 10.7314/apjcp.2015.16.12.5013.
3
Clinical Characteristics of Cerebrovascular Pathology with Patients Suffering from Ph-Negative Myeloproliferative Disease.伴有阴性骨髓增殖性疾病患者的脑血管病变的临床特征
Cerebrovasc Dis Extra. 2016;6(3):66-70. doi: 10.1159/000448597. Epub 2016 Sep 7.
4
The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.2001年世界卫生组织以及更新后的欧洲关于费城染色体阴性慢性骨髓增殖性疾病的诊断、分类及分期的临床和病理标准。
Semin Thromb Hemost. 2006 Jun;32(4 Pt 2):307-40. doi: 10.1055/s-2006-942754.
5
[Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases--principles and rationale of CZEMP recommendations].[BCR/ABL 阴性骨髓增殖性疾病的诊断与治疗——CZEMP 建议的原则与依据]
Vnitr Lek. 2011 Feb;57(2):189-213.
6
[Brain MRI-findings in Ph - negative myeloproliferative disorders].[Ph阴性骨髓增殖性疾病的脑部磁共振成像表现]
Ter Arkh. 2019 Jul 15;91(7):29-34. doi: 10.26442/00403660.2019.07.000329.
7
Assessment of Endothelial Dysfunction With Flow-Mediated Dilatation in Myeloproliferative Disorders.骨髓增殖性疾病中通过血流介导的血管舒张评估内皮功能障碍
Clin Appl Thromb Hemost. 2018 Oct;24(7):1102-1108. doi: 10.1177/1076029618766260. Epub 2018 Apr 22.
8
Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.骨髓增殖性疾病(原发性血小板增多症、真性红细胞增多症、原发性巨核细胞粒细胞化生及骨髓纤维化)的诊断、发病机制与治疗
Neth J Med. 1999 Feb;54(2):46-62. doi: 10.1016/s0300-2977(98)00143-0.
9
Influence of Blood Count, Cardiovascular Risks, Inherited Thrombophilia, and JAK2 V617F Burden Allele on Type of Thrombosis in Patients With Philadelphia Chromosome Negative Myeloproliferative Neoplasms.血细胞计数、心血管风险、遗传性血栓形成倾向、JAK2 V617F 负荷等位基因对费城染色体阴性骨髓增殖性肿瘤患者血栓类型的影响。
Clin Lymphoma Myeloma Leuk. 2019 Jan;19(1):53-63. doi: 10.1016/j.clml.2018.08.020. Epub 2018 Sep 10.
10
Thrombotic and hemorrhagic events in 2016 World Health Organization-defined Philadelphia-negative myeloproliferative neoplasm.2016 年世界卫生组织定义的费城阴性骨髓增殖性肿瘤中的血栓和出血事件。
Korean J Intern Med. 2021 Sep;36(5):1190-1203. doi: 10.3904/kjim.2020.634. Epub 2021 Jul 22.

引用本文的文献

1
Overview of dyslipidemia and metabolic syndrome in myeloproliferative neoplasms.骨髓增殖性肿瘤中的血脂异常与代谢综合征概述
World J Clin Oncol. 2024 Jun 24;15(6):717-729. doi: 10.5306/wjco.v15.i6.717.

本文引用的文献

1
The Role of Endothelial Dysfunction in the Pathophysiology and Cerebrovascular Effects of Migraine: A Narrative Review.内皮功能障碍在偏头痛病理生理学及脑血管效应中的作用:一项叙述性综述
J Clin Neurol. 2021 Apr;17(2):164-175. doi: 10.3988/jcn.2021.17.2.164.
2
Impact of comorbidities and body mass index on the outcome of polycythemia vera patients.合并症和体重指数对真性红细胞增多症患者结局的影响。
Hematol Oncol. 2021 Aug;39(3):409-418. doi: 10.1002/hon.2843. Epub 2021 Mar 8.
3
Hematocrit, hemoglobin and red blood cells are associated with vascular function and vascular structure in men.
红细胞比容、血红蛋白和红细胞与男性的血管功能和血管结构有关。
Sci Rep. 2020 Jul 10;10(1):11467. doi: 10.1038/s41598-020-68319-1.
4
Covert Brain Infarction: Towards Precision Medicine in Research, Diagnosis, and Therapy for a Silent Pandemic.隐匿性脑梗死:迈向针对这一无声大流行疾病的研究、诊断和治疗的精准医学
Stroke. 2020 Aug;51(8):2597-2606. doi: 10.1161/STROKEAHA.120.030686. Epub 2020 Jul 10.
5
Clinical characteristics and brain MRI findings in myeloproliferative neoplasms.骨髓增殖性肿瘤的临床特征及脑部磁共振成像表现
J Neurol Sci. 2020 Sep 15;416:116990. doi: 10.1016/j.jns.2020.116990. Epub 2020 Jun 19.
6
Ph myeloproliferative neoplasms and the related risk factors for stroke occurrence: Results from a registry of patients treated with Anagrelide.真性红细胞增多症骨髓增殖性肿瘤与中风发生的相关危险因素:使用阿那格雷治疗的患者登记结果
J Thromb Thrombolysis. 2021 Jan;51(1):112-119. doi: 10.1007/s11239-020-02175-8.
7
Epidemiology of the classical myeloproliferative neoplasms: The four corners of an expansive and complex map.经典骨髓增殖性肿瘤的流行病学:一幅广阔而复杂图谱的四个角落。
Blood Rev. 2020 Jul;42:100706. doi: 10.1016/j.blre.2020.100706. Epub 2020 May 22.
8
Preventing Covert Brain Infarct-Related Cognitive Impairment and Dementia.预防隐匿性脑梗死相关认知障碍和痴呆。
Can J Neurol Sci. 2020 Jul;47(4):456-463. doi: 10.1017/cjn.2020.45. Epub 2020 Mar 3.
9
Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis.验证 IPSET 评分在伴有前纤维化骨髓纤维化患者中的血栓形成风险。
Blood Cancer J. 2020 Feb 25;10(2):21. doi: 10.1038/s41408-020-0289-2.
10
Novel Biomarkers for Evaluation of Endothelial Dysfunction.用于评估血管内皮功能障碍的新型生物标志物。
Angiology. 2020 May;71(5):397-410. doi: 10.1177/0003319720903586. Epub 2020 Feb 20.